Biochemical Sciences Research Complex, School of Chemistry, University of St Andrews, North Haugh, KY16 9ST, St Andrews, UK.
ChemMedChem. 2022 Feb 16;17(4):e202100664. doi: 10.1002/cmdc.202100664. Epub 2022 Jan 5.
There is an urgent need for the development of new treatments against trypanosomatid parasites; the causative agents of some of the most debilitating diseases in the developing world. This work targets an interesting 6-5-6-6 fused carboline scaffold, accessing a range of substituted derivatives through stereospecific intramolecular Pictet-Spengler condensation. Modification of the cyclisation conditions allowed retention of the carbamate protecting group and gave insight into the reaction mechanism. Compounds' bioactivities were measured against T. brucei, T. cruzi, L. major and HeLa cells. We have identified promising pan-trypanocidal lead compounds based on the core scaffold, and highlight key SAR trends which will be useful for the future development of these compounds as potent trypanocidal agents.
迫切需要开发针对原生动物寄生虫的新疗法;这些寄生虫是发展中国家一些最具危害性疾病的病原体。本工作以有趣的 6-5-6-6 稠合咔啉骨架为目标,通过立体特异性的分子内皮克特-斯宾格勒缩合反应来获得一系列取代衍生物。通过改变环化条件,可以保留氨基甲酸酯保护基,并深入了解反应机制。对化合物进行了针对 T. brucei、T. cruzi、L. major 和 HeLa 细胞的生物活性测定。我们已经基于核心骨架确定了有前途的泛杀利什曼原虫先导化合物,并强调了关键的 SAR 趋势,这将有助于这些化合物作为有效的杀利什曼原虫药物的进一步开发。